The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
BGB-A317-212: A multicenter, open-label, phase II study to evaluate the efficacy and safety of tislelizumab in combination with lenvatinib in patients with selected solid tumors.
 
Yufei Liu
No Relationships to Disclose
 
Zhisong He
No Relationships to Disclose
 
Mingjun Zhang
No Relationships to Disclose
 
Shusuan Jiang
No Relationships to Disclose
 
Dahong Zhang
No Relationships to Disclose
 
Miao Feng
No Relationships to Disclose
 
Shenhong Qu
No Relationships to Disclose
 
Wutong Ju
Employment - BeiGene Shanghai
Stock and Other Ownership Interests - BeiGene Shanghai
 
Ke Wang
Employment - BeiGene
 
Ramil Abdrashitov
Employment - BeiGeneSA, Inc
Stock and Other Ownership Interests - AstraZeneca; BeiGene; Syndax
 
Jifeng Feng
No Relationships to Disclose